Legend Biotech Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-03-09 10:24:24 ET
More on Legend Biotech
- Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds
- Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Legend Biotech Arcellx rise after FDA draft guidance on multiple myeloma trials
- Seeking Alpha’s Quant Rating on Legend Biotech
- Historical earnings data for Legend Biotech
Read the full article on Seeking Alpha
For further details see:
Legend Biotech Q4 2025 Earnings Preview
Legend Biotech Corporation
NASDAQ: LEGN
LEGN Trading
1.18% G/L:
$35.03 Last:
1,639,225 Volume:
$34.975 Open:
LEGN Latest News
June 02, 2026 09:30:00 am
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
LEGN Stock Data
$3,309,357,827
166,569,786
N/A
63
N/A
Biotechnology & Life Sciences
Healthcare
US
Somerset
